Anti-inflammatory drug shows promise for treating alcoholism, UCLA study finds
The CTSI-supported clinical study was the first to find that ibudilast, a drug used in Japan mainly as a treatment for asthma and stroke, could reduce cravings for alcohol. Lara Ray, a professor of psychology and director of the UCLA Addictions Laboratory, was lead author of the study, which was conducted in the UCLA Clinical and Translational Research Center.
More information:
Read the UCLA press release
Read the publication in Neuropsychophamacology
Image caption:
Image source:
Related Articles
Final NIH Training Grant Changes Released | Effective Jan. 25, 2025
Final instructions have been released for NRSA Training Grants submitted on or after January 25th, 2025.
Civic Science AI Fellow selected by Center for SMART Health and CTSI
Mackensie Yore, an emergency physician researching health equity and the importance of human connection in medicine, has been selected as the first fellow.
UC BRAID: A clinical trial pilot pioneers a new era of collaboration, innovation and equity
UC BRAID: A clinical trial pilot pioneers a new era of collaboration, innovation and equity
CTSI GSU Training Grant Team Open Office Hours
Join the UCLA CTSI Grant Submission Unit’s Training Grant Office Hours on select Thursday from 11am – 12pm.